The Affect Of An Anti-Embolism Stocking Protocol
NCT06616376 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-09-27
Summary
This study was conducted to determine the effect of anti-embolism stocking (AES) use protocol affected the development of early venous thromboembolism (VTE) in patients undergoing total knee arthroplasty (TKA).
The randomized controlled single-blind intervention study included 40 patients (Experimental Group: 20, Control Group: 20) who underwent TKA surgery in a university hospital's Orthopedics and Traumatology clinic between 2019 and 2021. While the experimental group received the AES protocol one day before the operation and continued until the 10 th day after the operation, the control group received AES on the 0 th day after the operation and remained in the patient until the 21st day after the operation. In the study, a "Data Collection Form" with DVT and PE signs and symptoms was used.
Conditions
- Venous Thromboembolism
Interventions
- OTHER
-
Anti-Embolism Stocking
To prevent patients undergoing TKA surgery from being affected by one another, the patients were hospitalized in separate rooms, and the orthopedic clinic team was made aware of the situation. The patients in the control group were told not to remove their socks until the sutures were removed after the operation, whereas the patients in the experimental group were told to remove their socks on the 10th day after the operation, so the patients had no idea which group they were in.
Sponsors & Collaborators
-
Cukurova University
lead OTHER
Principal Investigators
-
Sevilay ERDEN, Assoc.Prof. · Ç.Ü Faculty of Health Sciences Department of Surgical Nursing
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-16
- Primary Completion
- 2021-02-17
- Completion
- 2021-02-17
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00371683 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
NCT06963320 ·Status: RECRUITING ·Phase: PHASE2
-
Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users
NCT01063426 ·Status: UNKNOWN ·Phase: PHASE4
-
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06180889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT03276143 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery
NCT00718224 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Aspirin in Preventing Venous Thromboembolism
NCT06635317 ·Status: COMPLETED ·Phase: PHASE4
-
Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy
NCT01542723 ·Status: COMPLETED ·Phase: NA
-
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
NCT00408239 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
NCT02271399 ·Status: COMPLETED ·Phase: PHASE2
-
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT06581965 ·Status: RECRUITING ·Phase: PHASE4
-
Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs
NCT03634124 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06825416 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery
NCT00697099 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
NCT00917254 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery
NCT00709904 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery
NCT00721760 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement
NCT00641732 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00541320 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA
NCT07140523 ·Status: RECRUITING ·Phase: PHASE2
-
Risk Stratification Procedure for Thromboembolism Prophylaxis
NCT04031859 ·Status: COMPLETED ·Phase: PHASE2
-
Enoxaparin in Acute Venous Thromboembolic Disease
NCT00265993 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement
NCT00362492 ·Status: COMPLETED ·Phase: PHASE4
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery
NCT00452530 ·Status: COMPLETED ·Phase: PHASE3
-
Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)
NCT00358735 ·Status: COMPLETED ·Phase: NA